Cargando…

Rapid on-site evaluation of touch imprints of medical thoracoscopy biopsy tissue for the management of pleural disease

BACKGROUND AND OBJECTIVE: Medical thoracoscopy (MT) plays an important role in the diagnosis and treatment of pleural diseases, and rapid on-site evaluation (ROSE) has long been used for transbronchial needle aspiration or fine-needle aspiration to evaluate the adequacy of biopsy materials for the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hansheng, Liu, Yan, Wang, Jiankun, Ren, Tao, Luo, Guoshi, You, Hui, Wang, Xiao, Li, Dan, Wang, Lei, Wang, Meifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288871/
https://www.ncbi.nlm.nih.gov/pubmed/37359022
http://dx.doi.org/10.3389/fmed.2023.1196000
_version_ 1785062164368719872
author Wang, Hansheng
Liu, Yan
Wang, Jiankun
Ren, Tao
Luo, Guoshi
You, Hui
Wang, Xiao
Li, Dan
Wang, Lei
Wang, Meifang
author_facet Wang, Hansheng
Liu, Yan
Wang, Jiankun
Ren, Tao
Luo, Guoshi
You, Hui
Wang, Xiao
Li, Dan
Wang, Lei
Wang, Meifang
author_sort Wang, Hansheng
collection PubMed
description BACKGROUND AND OBJECTIVE: Medical thoracoscopy (MT) plays an important role in the diagnosis and treatment of pleural diseases, and rapid on-site evaluation (ROSE) has long been used for transbronchial needle aspiration or fine-needle aspiration to evaluate the adequacy of biopsy materials for the diagnosis of peripheral lung lesions. However, research on ROSE combined with MT for the management of pleural disease has been rarely reported. We aimed to evaluate the diagnostic performance of ROSE for pleura biopsies and visual diagnosis by thoracoscopists for gross thoracoscopic appearance. The secondary objective was to assess the intermodality agreement between ROSE and the final histopathologic diagnosis. METHODS: A total of 579 patients with exudative pleural effusion (EPE) who underwent MT combined with ROSE from February 2017 to December 2020 at Taihe Hospital were included in the study. Thoracoscopists' visual diagnosis of gross thoracoscopic appearance, ROSE results, histopathologic findings, and the final diagnosis was recorded. RESULTS: Thoracoscopic pleural biopsies were performed in 565 patients (97.6%); 183 patients were confirmed to have malignant pleural effusion (MPE), and 382 patients were confirmed to have benign pleural effusion (BPE). The area under the curve of ROSE for the diagnosis of MPE was 0.96 (95% CI: 0.94–0.98, p < 0.001), with a sensitivity of 98.7%, a specificity of 97.2%, a diagnostic accuracy of 97.1%, a positive predictive value of 97.2%, and a negative predictive value of 97.2%. Diagnostic consistency between ROSE and histopathology was good (κ ± SE = 0.93 ± 0.02, p < 0.001). The area under the curve of the thoracoscopists' visual diagnosis of gross thoracoscopic appearance was 0.79 (95% CI: 0.75–0.83, p < 0.01), with a sensitivity of 76.7%, a specificity of 80.9%, a positive predictive value of 62.4%, and a negative predictive value of 89.3%. CONCLUSION: ROSE of touch imprints of MT biopsy tissue during MT showed high accuracy for distinguishing between benign and malignant lesions. In addition, ROSE was in good agreement with the histopathological diagnosis, which may help thoracoscopists perform pleurodesis (talc poudrage) directly during the procedure, especially in patients with malignant results.
format Online
Article
Text
id pubmed-10288871
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102888712023-06-24 Rapid on-site evaluation of touch imprints of medical thoracoscopy biopsy tissue for the management of pleural disease Wang, Hansheng Liu, Yan Wang, Jiankun Ren, Tao Luo, Guoshi You, Hui Wang, Xiao Li, Dan Wang, Lei Wang, Meifang Front Med (Lausanne) Medicine BACKGROUND AND OBJECTIVE: Medical thoracoscopy (MT) plays an important role in the diagnosis and treatment of pleural diseases, and rapid on-site evaluation (ROSE) has long been used for transbronchial needle aspiration or fine-needle aspiration to evaluate the adequacy of biopsy materials for the diagnosis of peripheral lung lesions. However, research on ROSE combined with MT for the management of pleural disease has been rarely reported. We aimed to evaluate the diagnostic performance of ROSE for pleura biopsies and visual diagnosis by thoracoscopists for gross thoracoscopic appearance. The secondary objective was to assess the intermodality agreement between ROSE and the final histopathologic diagnosis. METHODS: A total of 579 patients with exudative pleural effusion (EPE) who underwent MT combined with ROSE from February 2017 to December 2020 at Taihe Hospital were included in the study. Thoracoscopists' visual diagnosis of gross thoracoscopic appearance, ROSE results, histopathologic findings, and the final diagnosis was recorded. RESULTS: Thoracoscopic pleural biopsies were performed in 565 patients (97.6%); 183 patients were confirmed to have malignant pleural effusion (MPE), and 382 patients were confirmed to have benign pleural effusion (BPE). The area under the curve of ROSE for the diagnosis of MPE was 0.96 (95% CI: 0.94–0.98, p < 0.001), with a sensitivity of 98.7%, a specificity of 97.2%, a diagnostic accuracy of 97.1%, a positive predictive value of 97.2%, and a negative predictive value of 97.2%. Diagnostic consistency between ROSE and histopathology was good (κ ± SE = 0.93 ± 0.02, p < 0.001). The area under the curve of the thoracoscopists' visual diagnosis of gross thoracoscopic appearance was 0.79 (95% CI: 0.75–0.83, p < 0.01), with a sensitivity of 76.7%, a specificity of 80.9%, a positive predictive value of 62.4%, and a negative predictive value of 89.3%. CONCLUSION: ROSE of touch imprints of MT biopsy tissue during MT showed high accuracy for distinguishing between benign and malignant lesions. In addition, ROSE was in good agreement with the histopathological diagnosis, which may help thoracoscopists perform pleurodesis (talc poudrage) directly during the procedure, especially in patients with malignant results. Frontiers Media S.A. 2023-06-09 /pmc/articles/PMC10288871/ /pubmed/37359022 http://dx.doi.org/10.3389/fmed.2023.1196000 Text en Copyright © 2023 Wang, Liu, Wang, Ren, Luo, You, Wang, Li, Wang and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Wang, Hansheng
Liu, Yan
Wang, Jiankun
Ren, Tao
Luo, Guoshi
You, Hui
Wang, Xiao
Li, Dan
Wang, Lei
Wang, Meifang
Rapid on-site evaluation of touch imprints of medical thoracoscopy biopsy tissue for the management of pleural disease
title Rapid on-site evaluation of touch imprints of medical thoracoscopy biopsy tissue for the management of pleural disease
title_full Rapid on-site evaluation of touch imprints of medical thoracoscopy biopsy tissue for the management of pleural disease
title_fullStr Rapid on-site evaluation of touch imprints of medical thoracoscopy biopsy tissue for the management of pleural disease
title_full_unstemmed Rapid on-site evaluation of touch imprints of medical thoracoscopy biopsy tissue for the management of pleural disease
title_short Rapid on-site evaluation of touch imprints of medical thoracoscopy biopsy tissue for the management of pleural disease
title_sort rapid on-site evaluation of touch imprints of medical thoracoscopy biopsy tissue for the management of pleural disease
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288871/
https://www.ncbi.nlm.nih.gov/pubmed/37359022
http://dx.doi.org/10.3389/fmed.2023.1196000
work_keys_str_mv AT wanghansheng rapidonsiteevaluationoftouchimprintsofmedicalthoracoscopybiopsytissueforthemanagementofpleuraldisease
AT liuyan rapidonsiteevaluationoftouchimprintsofmedicalthoracoscopybiopsytissueforthemanagementofpleuraldisease
AT wangjiankun rapidonsiteevaluationoftouchimprintsofmedicalthoracoscopybiopsytissueforthemanagementofpleuraldisease
AT rentao rapidonsiteevaluationoftouchimprintsofmedicalthoracoscopybiopsytissueforthemanagementofpleuraldisease
AT luoguoshi rapidonsiteevaluationoftouchimprintsofmedicalthoracoscopybiopsytissueforthemanagementofpleuraldisease
AT youhui rapidonsiteevaluationoftouchimprintsofmedicalthoracoscopybiopsytissueforthemanagementofpleuraldisease
AT wangxiao rapidonsiteevaluationoftouchimprintsofmedicalthoracoscopybiopsytissueforthemanagementofpleuraldisease
AT lidan rapidonsiteevaluationoftouchimprintsofmedicalthoracoscopybiopsytissueforthemanagementofpleuraldisease
AT wanglei rapidonsiteevaluationoftouchimprintsofmedicalthoracoscopybiopsytissueforthemanagementofpleuraldisease
AT wangmeifang rapidonsiteevaluationoftouchimprintsofmedicalthoracoscopybiopsytissueforthemanagementofpleuraldisease